Galectin Therapeutics Inc. (FRA:PHPN)
Germany · Delayed Price · Currency is EUR 2.820
-0.340 (-10.76%)
At close: Jan 6, 2026
Galectin Therapeutics Market Cap
Galectin Therapeutics has a market cap or net worth of €174.6 million as of January 9, 2026. Its market cap has increased by 224.95% in one year.
Market Cap
174.60M
Enterprise Value
274.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.82
Market Cap Chart
Since September 4, 2002, Galectin Therapeutics's market cap has increased from 31.76M to 174.60M, an increase of 449.81%. That is a compound annual growth rate of 7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 174.60M | -23.57% |
| Dec 31, 2025 | 228.43M | 192.11% |
| Dec 31, 2024 | 78.20M | -15.81% |
| Dec 29, 2023 | 92.88M | 47.83% |
| Dec 30, 2022 | 62.83M | -41.83% |
| Dec 31, 2021 | 108.01M | 3.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |